Skip to content

Insider · CIK 0002105540

Bernard Barbour

officer

Files at SKIL (Skillsoft Corp.). First filing -, latest -.

Bernard Barbour files SEC Form 4 as officer at SKIL (Skillsoft Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Bernard Barbour has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 1, 2026SKIL
Skillsoft Corp.
AGrant or award
Restricted Stock Unitsderivative
+40,000$0.00$040,00040 d ago
Feb 18, 2026SKIL
Skillsoft Corp.
AGrant or award
Restricted Stock Unitsderivative
+47,500$0.00$047,500Feb 20, 2026

Questions about Bernard Barbour

Answered from the filings on this page, as of the latest one.

Is Bernard Barbour buying or selling?

Bernard Barbour has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Bernard Barbour's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bernard Barbour has 0.

Where does Bernard Barbour file Form 4?

Bernard Barbour has filed Form 4 at SKIL (Skillsoft Corp.) as Chief Tech & Product Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.